Covid-19 | CMC Vellore to conduct mixed-vaccine trial
The Hindu
DCGI nod is significant given shortage of Covaxin.
The Drug Controller General of India (DCGI) has approved a clinical trial, to be conducted by the Christian Medical College, Vellore, to evaluate if a mixed vaccine combination can work as opposed to the current policy of both doses being the same vaccine. India has administered 45.6 crore vaccine doses so far of which nearly 88% are Covishield. With limited supplies of Covaxin, a mixed dose regime may help cover a supply shortfall. “After detailed deliberation, the committee recommended for grant of permission for conduct of the Phase IV clinical trial,” said the minutes of the meeting that were made public on Friday, though details of the trial were not.More Related News